arrow
S

Sagar Lonial

emory university medical school
H指数:116
被引数:6.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events

Belantamab Mafodotin相关眼部事件的临床管理实用指南

2025-07-280
OAAI
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes

干细胞动员量与达鲁单抗(Dara)和来那度胺(Len)含药四联诱导疗法在 newly diagnosed multiple myeloma(NDMM)患者中的应用:2家机构真实世界经验

2025-04-110
PRE
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract

双特异性抗体给药模式的门诊可行性与安全性:国际骨髓瘤学会第21届年会口头摘要

2025-04-080
OAAI
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development ( vol 15, 15 , 2025)

Belantamab mafodotin在复发或难治性多发性骨髓瘤中的临床应用:药物开发经验教训(卷15,第15期,2025年)

2025-03-260
OA
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at Two Institutes

干细胞动员量与达雷妥尤单抗(Dara)和来那度胺(Len)联合的四药联合诱导疗法在 newly diagnosed multiple myeloma(NDMM)患者中的真实世界经验:一项来自两家机构的观察研究

BLOOD
IF23.1
2024-11-050
PRE
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination

mRNA疫苗接种后,SARS-CoV-2-specific浆细胞无法在骨髓长寿命区室中持久建立

2024-09-272
OAAI
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

新诊断的骨髓瘤的四联疗法: 在符合移植条件的患者中,来那度胺,硼替佐米和地塞米松 (RVd) 与达拉图单抗联合RVD (DRVd) 的序贯疗法的比较分析

2024-09-130
OAAI
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies
2024-08-212
OAAI
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

多发性骨髓瘤的综合分子谱分析可确定精细的拷贝数和表达亚型

2024-08-192
OAAI